Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 27373824 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| de-novo donor-specific anti-hla antibodies 30 days after lung transplantation are associated with a worse outcome. | |||||||
| 27373824 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| the impact of de-novo donor-specific anti-hla antibodies (dsa) on patient and graft survival after lung transplantation remains controversial. | |||||||
| 27450460 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | negation | |
| the effect of donor-specific anti-human leukocyte antigen (hla) antibodies (dsas) on graft survival is recognized in lung transplantation, but not all serum dsas appear to be harmful. | |||||||
| 27973391 | NA (NA) | lung transplantation | NA | NA | NA | unclassified | |
| a 3-center study reveals new insights into the impact of non-hla antibodies on lung transplantation outcome. | |||||||
| 28148598 | HLA (HLA) | lung transplantation | French | NA | NA | unclassified | |
| we characterized all patients using histopathology (ishlt [international society for heart and lung transplantation] 2013 grades), immunostaining, and circulating anti-hla donor-specific antibodies at the time of biopsy, together with systematic gene expression assessments of the allograft tissue, using microarrays. | |||||||
| 28375571 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| hla mismatching favoring host-versus-graft nk cell activity via kir3dl1 is associated with improved outcomes following lung transplantation. | |||||||
| 28701473 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| de novo donor-specific antibodies (dsas) to mismatched donor human leukocyte antigen after human lung transplantation predispose lung grafts to chronic rejection. | |||||||
| 29075627 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | positive+negation | |
| although donor-specific anti-human leukocyte antigen (hla) antibodies (dsas) are frequently found in recipients after lung transplantation (lt), the characteristics of dsa which influence antibody-mediated rejection (amr) in lt are not fully defined. | |||||||
| 29146602 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| donor-specific and -nonspecific hla antibodies and outcome post lung transplantation. | |||||||
| 29146602 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| donor-specific antibodies (dsas) against human leukocyte antigen (hla) are associated with chronic lung allograft dysfunction (clad) and mortality post lung transplantation, but data concerning prevalence, time of onset, persistence and effects on long-term outcome remain scarce.we assessed the association between hla antibodies and clad-free and graft survival in a cohort of 362 patients. | |||||||
Copyright 2024